Trial Profile
Retrospective study analyzing the role of c-Myc overexpression on the prognosis of multiple myeloma patients treated with bortezomib and dexamethasone
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Dec 2015
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Dexamethasone (Primary)
- Indications Multiple myeloma
- Focus Pharmacodynamics
- 19 Dec 2015 New trial record